Skip to main content
Screener/Healthcare/Biotechnology

IBRX — ImmunityBio, Inc.

NASDAQ
$8.46+0.70 (+9.05%)
Mid CapUnder $10HealthcareFastest GrowingHigh ROELow Beta
$1.91
$12.43
$7.58
$8.53
EPS (TTM)$-0.38
P/E Ratio-19.60
Dividend Yield—
Market Cap$7.30B
Volume13.64M
Prev Close$7.76
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$38.3M-$61.9M$-0.0688.9%-161.8%
Q3 '25$32.1M-$67.3M$-0.0787.1%-209.8%
Q2 '25$26.4M-$92.6M$-0.1099.5%-350.3%
Q1 '25$16.5M-$129.6M$-0.1599.6%-784.9%
Q4 '24$7.6M-$59.2M$-0.09100.0%-783.4%
Q3 '24$6.1M-$85.7M$-0.12100.0%-1404.0%
Q2 '24$1.0M-$134.6M$-0.20100.0%-12852.3%
Q1 '24$40K-$134.1M$-0.20100.0%-335272.5%
Get Your Daily Market Recap